{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:39:07Z","timestamp":1763987947261},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13722-019-0146-4","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:03:08Z","timestamp":1556668988000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Buprenorphine unobserved \u201chome\u201d induction: a survey of Ontario\u2019s addiction physicians"],"prefix":"10.1186","volume":"14","author":[{"given":"Anita","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meldon","family":"Kahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Leece","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"McAndrew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,1]]},"reference":[{"issue":"2","key":"146_CR1","first-page":"CD002207","volume":"2014","author":"RP Mattick","year":"2014","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2014(2):CD002207.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"146_CR2","first-page":"200","volume":"63","author":"A Srivastava","year":"2017","unstructured":"Srivastava A, Kahan M, Nader M. Primary care management of opioid use disorders: abstinence, methadone, or buprenorphine-naloxone? Can Fam Physician. 2017;63(3):200\u20135.","journal-title":"Can Fam Physician"},{"issue":"9","key":"146_CR3","doi-asserted-by":"publisher","first-page":"E247","DOI":"10.1503\/cmaj.170958","volume":"190","author":"J Bruneau","year":"2018","unstructured":"Bruneau J, Ahamad K, Goyer M, Poulin G, Selby P, Fischer B, et al. Management of opioid use disorders: a national clinical practice guideline. CMAJ. 2018;190(9):E247\u201357.","journal-title":"CMAJ"},{"key":"146_CR4","unstructured":"Network ODPR. Ontario prescription opioid tool Toronto Ontario. 2018. Available from: \n                    http:\/\/odprn.ca\/ontario-opioid-drug-observatory\/ontario-prescription-opioid-tool\/\n                    \n                  . Accessed 4 Dec 2018."},{"key":"146_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.31027\/ODPRN.2017.01","volume-title":"Latest trends in opioid-related deaths in Ontario: 1991 to 2015","author":"T Gomes","year":"2017","unstructured":"Gomes T, Greaves S, Martins D, et al. Latest trends in opioid-related deaths in Ontario: 1991 to 2015. Toronto: Ontario Drug Policy Research Network; 2017, p. 9."},{"key":"146_CR6","unstructured":"Ontario PH. Opioid-related morbidity and mortality in Ontario. 2018. Available from: \n                    https:\/\/www.publichealthontario.ca\/en\/dataandanalytics\/pages\/opioid.aspx#\/drug\n                    \n                  . Accessed 4 Dec 2018."},{"key":"146_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.31027\/ODPRN.2017.04","volume-title":"Behind the prescriptions: a snapshot of opioid use across all Ontarians","author":"T Gomes","year":"2017","unstructured":"Gomes T, Pasricha S, Martins D, Greaves S, et al. Behind the prescriptions: a snapshot of opioid use across all Ontarians. Toronto: Ontario Drug Policy Research Network; 2017, p. 19."},{"key":"146_CR8","volume-title":"Buprenorphine\/naloxone for opioid dependence: clinical practice guideline","author":"MK Curtis Handford","year":"2011","unstructured":"Curtis Handford MK, Srivastava A, Cirone S, Sanghera S, Palda V. Buprenorphine\/naloxone for opioid dependence: clinical practice guideline. Toronto: Centre for Addiction and Mental Health, University of Toronto; 2011."},{"key":"146_CR9","unstructured":"Center for substance abuse treatment. clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment Improvement Protocol (TIP) Series 40. Rockville, MD, USA: DHHS, Substance Abuse and Mental Health Services Administration; 2004."},{"issue":"8","key":"146_CR10","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1176\/ps.2008.59.8.909","volume":"59","author":"CP Thomas","year":"2008","unstructured":"Thomas CP, Reif S, Haq S, Wallack SS, Hoyt A, Ritter GA. Use of buprenorphine for addiction treatment: perspectives of addiction specialists and general psychiatrists. Psychiatr Serv. 2008;59(8):909\u201316.","journal-title":"Psychiatr Serv"},{"issue":"3","key":"146_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jsat.2008.06.006","volume":"36","author":"J Netherland","year":"2009","unstructured":"Netherland J, Botsko M, Egan JE, Saxon AJ, Cunningham CO, Finkelstein R, et al. Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat. 2009;36(3):244\u201351.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"146_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1300\/J069v25n04_09","volume":"25","author":"W Kissin","year":"2006","unstructured":"Kissin W, McLeod C, Sonnefeld J, Stanton A. Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence. J Addict Dis. 2006;25(4):91\u2013103.","journal-title":"J Addict Dis"},{"issue":"4","key":"146_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/ADM.0b013e31821ee8fe","volume":"5","author":"EW Gunderson","year":"2011","unstructured":"Gunderson EW. Buprenorphine induction: a major barrier for physician adoption of office-based opioid dependence treatment. J Addict Med. 2011;5(4):304\u20135.","journal-title":"J Addict Med"},{"issue":"2","key":"146_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s11606-008-0866-8","volume":"24","author":"JD Lee","year":"2009","unstructured":"Lee JD, Grossman E, DiRocco D, Gourevitch MN. Home buprenorphine\/naloxone induction in primary care. J Gen Intern Med. 2009;24(2):226\u201332.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"146_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/ADM.0000000000000059","volume":"8","author":"JD Lee","year":"2014","unstructured":"Lee JD, Vocci F, Fiellin DA. Unobserved \u201chome\u201d induction onto buprenorphine. J Addict Med. 2014;8(5):299\u2013308.","journal-title":"J Addict Med"},{"issue":"9","key":"146_CR16","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s11606-008-0686-x","volume":"23","author":"AY Walley","year":"2008","unstructured":"Walley AY, Alperen JK, Cheng DM, Botticelli M, Castro-Donlan C, Samet JH, et al. Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. J Gen Intern Med. 2008;23(9):1393\u20138.","journal-title":"J Gen Intern Med"},{"key":"146_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2016.10.005","volume":"74","author":"A Kermack","year":"2017","unstructured":"Kermack A, Flannery M, Tofighi B, McNeely J, Lee JD. Buprenorphine prescribing practice trends and attitudes among New York providers. J Subst Abuse Treat. 2017;74:1\u20136.","journal-title":"J Subst Abuse Treat"},{"key":"146_CR18","unstructured":"CRISM national guideline for the clinical management of opioid use disorder. Canadian Research Initiative on Substance Misuse (CRISM), Canadian Institutes of Health Research (CIHR); 2018."},{"key":"146_CR19","volume-title":"National practice guideline for the use of medications in the treatment of addiction involving opioid use","author":"American Society of Addiction Medicine","year":"2015","unstructured":"American Society of Addiction Medicine. National practice guideline for the use of medications in the treatment of addiction involving opioid use. Chevy Chase: American Society of Addiction Medicine (ASAM); 2015."},{"issue":"5","key":"146_CR20","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","volume":"9","author":"K Kampman","year":"2015","unstructured":"Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med. 2015;9(5):358\u201367.","journal-title":"J Addict Med"}],"container-title":["Addiction Science & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-019-0146-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13722-019-0146-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-019-0146-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T23:13:51Z","timestamp":1588202031000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-019-0146-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["146"],"URL":"https:\/\/doi.org\/10.1186\/s13722-019-0146-4","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,1]]},"assertion":[{"value":"11 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"18"}}